Biological Products, (No Diagnostic Substances) · DE · CIK 1468748
Develops and commercializes next-generation retinal therapeutics using its Antibody Biopolymer Conjugate platform
Comparable business profile · signals at a glance
In the 90 days to Dec 18, 2025: 1 insider bought $60.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 18, 2025 | Baker Brothers Life Sciences LpDirector,TenPercentOwner | Buy | 2,391,268 | $23.00 | $55.0M |
| Dec 18, 2025 | Baker Brothers Life Sciences LpDirector,TenPercentOwner | Buy | 217,428 | $23.00 | $5.0M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.